Classified in:Covid-19 virus

GUELPH, ON / ACCESSWIRE / January 14, 2022 / Zentek Ltd. (“ZEN” or the “Company“) (TSXV:ZEN)(OTC PINK:ZENYF), an IP development and commercialization company focused on next-gen healthcare solutions, announces the granting of 1,300,000 options to directors, officers and employees of the company exercisable at a price of $4.25 per common share for a period of three to five years from the date of the grant. The options will vest one-third on the date of grant, one-third after six months of the date of grant and one-third after 12 months of the date of grant.

About Zentek Ltd.

Zentek is a nanotechnology company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZENGuard™, a patent-pending coating shown to have 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed aptamer-based rapid pathogen detection technology.

For further information:
Matt Blazei
Tel: (212) 655-0924

To find out more about Zentek Ltd., please visit our website at A copy of this news release and all material documents in respect of the Company may be obtained on ZEN’s SEDAR profile at

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Zentek Ltd.

View source version on

These press releases may also interest you

at 19:30

The “Baked Market by Product (Bread and rolls, Cakes and pastries, Cookies, and Others) and Geographic (APAC, Europe, North America, South America, and MEA) – Forecast and Analysis 2021-2025” report has been added to Technavio’s offering. With ISO…

at 19:30

Zentek Ltd. ("ZEN" or the "Company") , an IP development and commercialization company focused on next-gen healthcare solutions, announces the granting of 1,300,000 options to directors, officers and employees of the company…

at 19:20

SOL Global Investments Corp. (the “Company” or “SOL Global”) announces that on December 20, 2021 it acquired ownership of 62,500 common shares (the “Common Shares”) in the capital of Atmofizer Technologies Inc. (“ATMO”) on the Canadian Securities…

at 18:30

The “Third-party Banking Software Market – Competitive Analysis, Drivers, Challenges & Five Force Analysis” report has been added to Technavio’s offering. 33% of the market’s growth will originate from Europe during the forecast period. UK,…

at 17:55

National Association of Chain Drug Stores (NACDS) President & CEO Steven C. Anderson issued the following statement today to advise Americans in advance of the federal government’s rollout of an effort to enhance the availability of over-the-counter…

at 17:50

Atmofizer Technologies Inc. (formerly Consolidated HCI Holdings Corporation) (the “Company” or “Atmofizer”) is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”)…

News published on 14 january 2022 at 19:30 and distributed by:

Read more at: ‘ + document.location.href,
copytext = selection + pagelink,
newdiv = document.createElement(‘div’); = ‘absolute’; = ‘-99999px’;
newdiv.innerHTML = copytext;
window.setTimeout(function () {
}, 100);
document.addEventListener(‘copy’, addLink);